News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

Cardioneural ablation provides a new treatment option for vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Experts raise concern about high cost-sharing for imaging in some Medicare Advantage plans

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology.

cybersecurity cyberattack hack hackers lock protection

Homeland Security warns of vulnerabilities in medical imaging software

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers.

University opens $30M new research imaging center focused on liver disease

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments.

PwC predicts: Providers, payers, pharma, medtech—all will have new to-do lists after the midterm elections. And that’s regardless of results.

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in?

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.

Around the web

Cardiovascular Business

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiovascular Business

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

Cardiovascular Business

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?